|
| ID |
DDInter1697 |
| Drug Type |
small molecule |
| Molecular Formula |
C10H14N2O2 |
| Molecular Weight |
194.234
|
| Description |
Solriamfetol marketed under the brand name Sunosi by Jazz Pharmaceuticals in the United States is a dopamine and norepinephrine reuptake inhibitor (DNRI) indicated in treating daytime sleepiness associated with narcolepsy or obstructive sleep apnea[FDA Label]. Solriamfetol was given FDA approval in 2019[FDA Label].
|
| ATC Classification |
N06BA14
|
| IUPAC Name |
(2R)-2-Amino-3-Phenylpropyl Carbamate |
| InChI |
Inchi=1S/C10H14N2O2/C11-9(7-14-10(12)13)6-8-4-2-1-3-5-8/H1-5,9H,6-7,11H2,(H2,12,13)/T9-/M1/S1 |
| InChI Key |
UCTRAOBQFUDCSR-SECBINFHSA-N |
| Canonical SMILES |
N[C@@H](COC(N)=O)CC1=CC=CC=C1 |
| Useful Links |
DrugBank
ChEMBL
|